Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Résultat de la recherche
6 recherche sur le mot-clé 'Cannabis'
Affiner la recherche Générer le flux rss de la recherche
Partager le résultat de cette recherche Faire une suggestion
Peri-Pregnancy Cannabis Use and Autism Spectrum Disorder in the Offspring: Findings from the Study to Explore Early Development / Carolyn G. DIGUISEPPI in Journal of Autism and Developmental Disorders, 52-11 (November 2022)
[article]
Titre : Peri-Pregnancy Cannabis Use and Autism Spectrum Disorder in the Offspring: Findings from the Study to Explore Early Development Type de document : Texte imprimé et/ou numérique Auteurs : Carolyn G. DIGUISEPPI, Auteur ; Tessa CRUME, Auteur ; Julia VAN DYKE, Auteur ; Katherine R. SABOURIN, Auteur ; Gnakub N. SOKE, Auteur ; Lisa A. CROEN, Auteur ; Julie L. DANIELS, Auteur ; Li-Ching LEE, Auteur ; Laura A. SCHIEVE, Auteur ; Gayle C. WINDHAM, Auteur ; Sandra FRIEDMAN, Auteur ; Cordelia ROBINSON ROSENBERG, Auteur Article en page(s) : p.5064-5071 Langues : Anglais (eng) Mots-clés : Autism Spectrum Disorder/epidemiology Cannabis/adverse effects Case-Control Studies Female Humans Pregnancy Autism spectrum disorder Cannabis Epidemiology Marijuana interest. Index. décimale : PER Périodiques Résumé : The association of autism spectrum disorder (ASD) with self-reported maternal cannabis use from 3Â months pre-conception to delivery ("peri-pregnancy") was assessed in children aged 30-68Â months, born 2003 to 2011. Children with ASD (N=1428) were compared to children with other developmental delays/disorders (DD, N=1198) and population controls (POP, N=1628). Peri-pregnancy cannabis use was reported for 5.2% of ASD, 3.2% of DD and 4.4% of POP children. Adjusted odds of peri-pregnancy cannabis use did not differ significantly between ASD cases and DD or POP controls. Results were similar for any use during pregnancy. However, given potential risks suggested by underlying neurobiology and animal models, further studies in more recent cohorts, in which cannabis use and perception may have changed, are needed. En ligne : http://dx.doi.org/10.1007/s10803-021-05339-4 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=489
in Journal of Autism and Developmental Disorders > 52-11 (November 2022) . - p.5064-5071[article] Peri-Pregnancy Cannabis Use and Autism Spectrum Disorder in the Offspring: Findings from the Study to Explore Early Development [Texte imprimé et/ou numérique] / Carolyn G. DIGUISEPPI, Auteur ; Tessa CRUME, Auteur ; Julia VAN DYKE, Auteur ; Katherine R. SABOURIN, Auteur ; Gnakub N. SOKE, Auteur ; Lisa A. CROEN, Auteur ; Julie L. DANIELS, Auteur ; Li-Ching LEE, Auteur ; Laura A. SCHIEVE, Auteur ; Gayle C. WINDHAM, Auteur ; Sandra FRIEDMAN, Auteur ; Cordelia ROBINSON ROSENBERG, Auteur . - p.5064-5071.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 52-11 (November 2022) . - p.5064-5071
Mots-clés : Autism Spectrum Disorder/epidemiology Cannabis/adverse effects Case-Control Studies Female Humans Pregnancy Autism spectrum disorder Cannabis Epidemiology Marijuana interest. Index. décimale : PER Périodiques Résumé : The association of autism spectrum disorder (ASD) with self-reported maternal cannabis use from 3Â months pre-conception to delivery ("peri-pregnancy") was assessed in children aged 30-68Â months, born 2003 to 2011. Children with ASD (N=1428) were compared to children with other developmental delays/disorders (DD, N=1198) and population controls (POP, N=1628). Peri-pregnancy cannabis use was reported for 5.2% of ASD, 3.2% of DD and 4.4% of POP children. Adjusted odds of peri-pregnancy cannabis use did not differ significantly between ASD cases and DD or POP controls. Results were similar for any use during pregnancy. However, given potential risks suggested by underlying neurobiology and animal models, further studies in more recent cohorts, in which cannabis use and perception may have changed, are needed. En ligne : http://dx.doi.org/10.1007/s10803-021-05339-4 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=489 Brief Report: Suspected Cannabis-Induced Mania and Psychosis in Young Adult Males with Autism Spectrum Disorder / Majd AL-SOLEITI in Journal of Autism and Developmental Disorders, 52-9 (September 2022)
[article]
Titre : Brief Report: Suspected Cannabis-Induced Mania and Psychosis in Young Adult Males with Autism Spectrum Disorder Type de document : Texte imprimé et/ou numérique Auteurs : Majd AL-SOLEITI, Auteur ; Kayla BALAJ, Auteur ; Robyn P. THOM, Auteur ; Christopher J. MCDOUGLE, Auteur ; Christopher J. KEARY, Auteur Article en page(s) : p.4164-4171 Langues : Anglais (eng) Mots-clés : Autism Spectrum Disorder/diagnosis/etiology Cannabis Humans Male Mania Psychotic Disorders/etiology Retrospective Studies Young Adult Autism Autism spectrum disorder Cannabidiol Clinical trials Delta-9-tetrahydrocannabinol Index. décimale : PER Périodiques Résumé : There is increasing interest in investigating cannabis for behavioral symptoms in individuals with autism spectrum disorder (ASD). The potential role of dysregulated cannabinoid signaling contributing to the pathophysiology of ASD is an area of active investigation. Results from retrospective and uncontrolled trials of cannabis in subjects with ASD have been published, reporting both potential benefits and adverse effects. Here, we describe the clinical course of three young adult males with ASD who developed mania or psychosis after the consistent use of cannabidiol and delta-9-tetrahydrocannabinol. Caution should be utilized with cannabis use in individuals with ASD until large-scale, replicated randomized controlled trials demonstrating efficacy, safety and tolerability have been published. En ligne : http://dx.doi.org/10.1007/s10803-021-05254-8 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=486
in Journal of Autism and Developmental Disorders > 52-9 (September 2022) . - p.4164-4171[article] Brief Report: Suspected Cannabis-Induced Mania and Psychosis in Young Adult Males with Autism Spectrum Disorder [Texte imprimé et/ou numérique] / Majd AL-SOLEITI, Auteur ; Kayla BALAJ, Auteur ; Robyn P. THOM, Auteur ; Christopher J. MCDOUGLE, Auteur ; Christopher J. KEARY, Auteur . - p.4164-4171.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 52-9 (September 2022) . - p.4164-4171
Mots-clés : Autism Spectrum Disorder/diagnosis/etiology Cannabis Humans Male Mania Psychotic Disorders/etiology Retrospective Studies Young Adult Autism Autism spectrum disorder Cannabidiol Clinical trials Delta-9-tetrahydrocannabinol Index. décimale : PER Périodiques Résumé : There is increasing interest in investigating cannabis for behavioral symptoms in individuals with autism spectrum disorder (ASD). The potential role of dysregulated cannabinoid signaling contributing to the pathophysiology of ASD is an area of active investigation. Results from retrospective and uncontrolled trials of cannabis in subjects with ASD have been published, reporting both potential benefits and adverse effects. Here, we describe the clinical course of three young adult males with ASD who developed mania or psychosis after the consistent use of cannabidiol and delta-9-tetrahydrocannabinol. Caution should be utilized with cannabis use in individuals with ASD until large-scale, replicated randomized controlled trials demonstrating efficacy, safety and tolerability have been published. En ligne : http://dx.doi.org/10.1007/s10803-021-05254-8 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=486 Caregivers' views on cannabis use for their children with autism / Taylor T. SIVORI in Research in Autism Spectrum Disorders, 102 (April 2023)
[article]
Titre : Caregivers' views on cannabis use for their children with autism Type de document : Texte imprimé et/ou numérique Auteurs : Taylor T. SIVORI, Auteur ; Maclain CAPRON, Auteur ; Daniel GRAVES, Auteur ; Jill HARRIS, Auteur ; Roseann C. SCHAAF, Auteur Article en page(s) : p.102130 Langues : Anglais (eng) Mots-clés : Autism ASD Cannabis Caregiver Knowledge Survey Index. décimale : PER Périodiques Résumé : Background Autism is a neurodevelopmental disorder impacting 1 in 44 children that is characterized by decreased social communication and problem behaviors. Despite the increasing accessibility of cannabis, there is limited guidance about its use and usefulness for autism. The purpose of this study is to query caregivers of autistic children about their experience, knowledge and interest in medical cannabis use for their children. Method Survey methodology was used to query caregivers of autistic children between ages five to ten years. Informants recruited through a large children?s hospital in New Jersey and the Autism Speaks website. Descriptive analyses of frequencies and percentages are reported and relationships among socio-demographic variables and survey responses were conducted. Results Of the 4385 surveys sent, 568 responded. Informants were primarily white or Latino, female, and without a college education. Most were not familiar with cannabis use in autism; 7.2 % had experience providing their child with cannabis. Information about cannabis was drawn mainly from the Internet. Eighty-five percent of participants reported that they were willing to try cannabis for their child with ASD to address difficulty focusing, hyperactivity, sensory sensitivities, and anxiety. About half of those respondents were concerned about interactions between cannabis and current medications. Conclusions Findings suggest a willingness among caregivers to use cannabis for their children with ASD, but a need for more informed guidance on this topic. More studies are needed to understand the utility of cannabis for autistic individuals; clear and reputable information about cannabis and ASD is needed. En ligne : https://doi.org/10.1016/j.rasd.2023.102130 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=501
in Research in Autism Spectrum Disorders > 102 (April 2023) . - p.102130[article] Caregivers' views on cannabis use for their children with autism [Texte imprimé et/ou numérique] / Taylor T. SIVORI, Auteur ; Maclain CAPRON, Auteur ; Daniel GRAVES, Auteur ; Jill HARRIS, Auteur ; Roseann C. SCHAAF, Auteur . - p.102130.
Langues : Anglais (eng)
in Research in Autism Spectrum Disorders > 102 (April 2023) . - p.102130
Mots-clés : Autism ASD Cannabis Caregiver Knowledge Survey Index. décimale : PER Périodiques Résumé : Background Autism is a neurodevelopmental disorder impacting 1 in 44 children that is characterized by decreased social communication and problem behaviors. Despite the increasing accessibility of cannabis, there is limited guidance about its use and usefulness for autism. The purpose of this study is to query caregivers of autistic children about their experience, knowledge and interest in medical cannabis use for their children. Method Survey methodology was used to query caregivers of autistic children between ages five to ten years. Informants recruited through a large children?s hospital in New Jersey and the Autism Speaks website. Descriptive analyses of frequencies and percentages are reported and relationships among socio-demographic variables and survey responses were conducted. Results Of the 4385 surveys sent, 568 responded. Informants were primarily white or Latino, female, and without a college education. Most were not familiar with cannabis use in autism; 7.2 % had experience providing their child with cannabis. Information about cannabis was drawn mainly from the Internet. Eighty-five percent of participants reported that they were willing to try cannabis for their child with ASD to address difficulty focusing, hyperactivity, sensory sensitivities, and anxiety. About half of those respondents were concerned about interactions between cannabis and current medications. Conclusions Findings suggest a willingness among caregivers to use cannabis for their children with ASD, but a need for more informed guidance on this topic. More studies are needed to understand the utility of cannabis for autistic individuals; clear and reputable information about cannabis and ASD is needed. En ligne : https://doi.org/10.1016/j.rasd.2023.102130 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=501 Predictors of problematic adult alcohol, cannabis, and other substance use: A longitudinal study of two samples / Natalie GOULTER ; Jennifer GODWIN ; Robert J. MCMAHON ; Kenneth A. DODGE ; Max CROWLEY ; Gregory S. PETTIT ; John E. BATES ; John E. LOCHMAN in Development and Psychopathology, 35-4 (October 2023)
[article]
Titre : Predictors of problematic adult alcohol, cannabis, and other substance use: A longitudinal study of two samples Type de document : Texte imprimé et/ou numérique Auteurs : Natalie GOULTER, Auteur ; Jennifer GODWIN, Auteur ; Robert J. MCMAHON, Auteur ; Kenneth A. DODGE, Auteur ; Max CROWLEY, Auteur ; Gregory S. PETTIT, Auteur ; John E. BATES, Auteur ; John E. LOCHMAN, Auteur Article en page(s) : p.2028-2043 Langues : Anglais (eng) Mots-clés : alcohol cannabis development risk factors substance use Index. décimale : PER Périodiques Résumé : This study examined whether a key set of adolescent and early adulthood risk factors predicts problematic alcohol, cannabis, and other substance use in established adulthood. Two independent samples from the Child Development Project (CDP; n = 585; 48% girls; 81% White, 17% Black, 2% other race/ethnicity) and Fast Track (FT; n = 463; 45% girls; 52% White, 43% Black, 5% other race/ethnicity) were recruited in childhood and followed through age 34 (CDP) or 32 (FT). Predictors of substance use were assessed in adolescence based on adolescent and parent reports and in early adulthood based on adult self-reports. Adults reported their own problematic substance use in established adulthood. In both samples, more risk factors from adolescence and early adulthood predicted problematic alcohol use in established adulthood (compared to problematic cannabis use and other substance use). Externalizing behaviors and prior substance use in early adulthood were consistent predictors of problematic alcohol and cannabis misuse in established adulthood across samples; other predictors were specific to the sample and type of substance misuse. Prevention efforts might benefit from tailoring to address risk factors for specific substances, but prioritizing prevention of externalizing behaviors holds promise for preventing both alcohol and cannabis misuse in established adulthood. En ligne : https://dx.doi.org/10.1017/S0954579422000670 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=515
in Development and Psychopathology > 35-4 (October 2023) . - p.2028-2043[article] Predictors of problematic adult alcohol, cannabis, and other substance use: A longitudinal study of two samples [Texte imprimé et/ou numérique] / Natalie GOULTER, Auteur ; Jennifer GODWIN, Auteur ; Robert J. MCMAHON, Auteur ; Kenneth A. DODGE, Auteur ; Max CROWLEY, Auteur ; Gregory S. PETTIT, Auteur ; John E. BATES, Auteur ; John E. LOCHMAN, Auteur . - p.2028-2043.
Langues : Anglais (eng)
in Development and Psychopathology > 35-4 (October 2023) . - p.2028-2043
Mots-clés : alcohol cannabis development risk factors substance use Index. décimale : PER Périodiques Résumé : This study examined whether a key set of adolescent and early adulthood risk factors predicts problematic alcohol, cannabis, and other substance use in established adulthood. Two independent samples from the Child Development Project (CDP; n = 585; 48% girls; 81% White, 17% Black, 2% other race/ethnicity) and Fast Track (FT; n = 463; 45% girls; 52% White, 43% Black, 5% other race/ethnicity) were recruited in childhood and followed through age 34 (CDP) or 32 (FT). Predictors of substance use were assessed in adolescence based on adolescent and parent reports and in early adulthood based on adult self-reports. Adults reported their own problematic substance use in established adulthood. In both samples, more risk factors from adolescence and early adulthood predicted problematic alcohol use in established adulthood (compared to problematic cannabis use and other substance use). Externalizing behaviors and prior substance use in early adulthood were consistent predictors of problematic alcohol and cannabis misuse in established adulthood across samples; other predictors were specific to the sample and type of substance misuse. Prevention efforts might benefit from tailoring to address risk factors for specific substances, but prioritizing prevention of externalizing behaviors holds promise for preventing both alcohol and cannabis misuse in established adulthood. En ligne : https://dx.doi.org/10.1017/S0954579422000670 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=515 Anxiété et troubles neuropsychologiques: résumés de 5 conférences présentées lors du symposium au Québec / Francine LUSSIER in Approche Neuropsychologique des Apprentissages chez l'Enfant - A.N.A.E., 158 (Février 2019)
[article]
Titre : Anxiété et troubles neuropsychologiques: résumés de 5 conférences présentées lors du symposium au Québec Type de document : Texte imprimé et/ou numérique Auteurs : Francine LUSSIER, Auteur Année de publication : 2019 Article en page(s) : p.19-26 Langues : Français (fre) Mots-clés : Anxiété de performance Base neurobiologique de l’anxiété Réalité virtuelle Cannabis Réseaux sociaux Index. décimale : PER Périodiques Résumé : L’anxiété associés à des troubles neurodéveloppementaux peut être chronique, récurrente et provoquer une profonde détresse. Si la peur (ou à un moindre degré, le stress) est une réponse adéquate et adaptative face à une menace imminente (ou face à une demande de performance), la persistance ou l’ampleur de cette peur signera au contraire la naissance d’un trouble anxieux. Pour ouvrir le symposium, Sonia Lupien nous a entretenus sur le stress normal et le développement de l’anxiété de performance chez les enfants et les adolescents. A la suite de sa présentation, Claire Dominique Walker nous a présenté des modèles animaux sur le développement de l’anxiété pour nous permettre de mieux comprendre les bases neurologiques de l’anxiété et sa trajectoire développementale qui influence les réponses comportementales à long terme. Stéphane Bouchard a abordé cette nouvelle technologie qu’est la réalité virtuelle pour intervenir auprès des enfants anxieux puis, Jean-Sébastien Fallu a discuté de l’anxiété dans le contexte de la légalisation du cannabis au Canada. Le symposium s’est terminé par un panel sur la place des réseaux sociaux dans les manifestations de l’anxiété. Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=385
in Approche Neuropsychologique des Apprentissages chez l'Enfant - A.N.A.E. > 158 (Février 2019) . - p.19-26[article] Anxiété et troubles neuropsychologiques: résumés de 5 conférences présentées lors du symposium au Québec [Texte imprimé et/ou numérique] / Francine LUSSIER, Auteur . - 2019 . - p.19-26.
Langues : Français (fre)
in Approche Neuropsychologique des Apprentissages chez l'Enfant - A.N.A.E. > 158 (Février 2019) . - p.19-26
Mots-clés : Anxiété de performance Base neurobiologique de l’anxiété Réalité virtuelle Cannabis Réseaux sociaux Index. décimale : PER Périodiques Résumé : L’anxiété associés à des troubles neurodéveloppementaux peut être chronique, récurrente et provoquer une profonde détresse. Si la peur (ou à un moindre degré, le stress) est une réponse adéquate et adaptative face à une menace imminente (ou face à une demande de performance), la persistance ou l’ampleur de cette peur signera au contraire la naissance d’un trouble anxieux. Pour ouvrir le symposium, Sonia Lupien nous a entretenus sur le stress normal et le développement de l’anxiété de performance chez les enfants et les adolescents. A la suite de sa présentation, Claire Dominique Walker nous a présenté des modèles animaux sur le développement de l’anxiété pour nous permettre de mieux comprendre les bases neurologiques de l’anxiété et sa trajectoire développementale qui influence les réponses comportementales à long terme. Stéphane Bouchard a abordé cette nouvelle technologie qu’est la réalité virtuelle pour intervenir auprès des enfants anxieux puis, Jean-Sébastien Fallu a discuté de l’anxiété dans le contexte de la légalisation du cannabis au Canada. Le symposium s’est terminé par un panel sur la place des réseaux sociaux dans les manifestations de l’anxiété. Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=385 Le livre noir de l'autisme / Olivia CATTAN
Permalink